Advertisement

Bio-Rad Laboratories, Inc. BIO.B

Set alert

Price alert · BIO.B

All alert types
379.50 USD 0.00 0.00%

At close · Oct 30

387.21 +7.71 +2.03%

After hours · Oct 30, 4:10 PM ET

Bid
370.70 × 1
Ask
415.73 × 1
379.50 Day range 379.50
244.54 52-week range 379.50
YTD
+22.14%
1 year
+25.19%
Open
379.50
Prev close
379.50
Mkt cap
10.16B
Vol
14
Avg vol
9
EPS
7.89
P/E
48.10
Div yield
0.00%
More statistics
Low
379.50
High
379.50
Forward P/E
33.78
Beta
1.08
Short ratio
0.00
Inst. own
0.08%
Dividend
0.00
Ex-div date
50-d avg
288.90
200-d avg
292.78
1y target
0.00

6M chart

Chart tools
Interval

Signals (17)
NameDateAgo
MACD: Buy SignalOct 27, 20265 days ago
MACD: Sell SignalSep 3, 20261 month ago
MACD: Buy SignalAug 20, 20262 months ago
MACD: Sell SignalAug 19, 20262 months ago
MACD: Buy SignalAug 3, 20263 months ago
MACD: Sell SignalJul 29, 20263 months ago
MACD: Buy SignalJul 14, 20263 months ago
RSI: OverboughtJul 13, 20263 months ago
MACD: Sell SignalJun 17, 20264 months ago
SMA: BullishMay 27, 20265 months ago
SMA: BullishMay 27, 20265 months ago
RSI: OverboughtMay 27, 20265 months ago
MACD: Buy SignalMay 22, 20265 months ago
SMA: BearishMay 5, 20266 months ago
SMA: BearishMay 5, 20266 months ago
MACD: Sell SignalMay 5, 20266 months ago
RSI: OversoldMay 5, 20266 months ago

Key statistics

Market cap
7.99B
Enterprise value
7.75B
Trailing P/E
49.75
Forward P/E
33.78
PEG ratio
1.21
Price / sales
3.08
Price / book
1.17
EPS (TTM)
6.00
Beta
1.08
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
6.52%
Revenue (TTM)
2.59B
Revenue growth
1.10%
Free cash flow
78.10M
Total cash
1.56B
Total debt
1.38B
Return on equity
2.50%
Shares outstanding
5.06M
Short % of float
0.01%
50-day average
288.90
200-day average
292.78

Analyst view

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Employees
7,450
Website
bio-rad.com

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on BIO.B — it syncs with the Stock Master app.

Advertisement